Publication date: 
10 March 2011
Last updated: 
19 December 2017
Publication type: 
Intended audience: 
Health professionals

Review by Professor John Horvath AO MBBS FRACP on the management of adverse events associated with Panvax and Fluvax for influenza vaccinations.

The Report considers influenza vaccine adverse event reporting in 2010. It then describes:

  • the Australian regulatory system for drugs and vaccines
  • how the post-marketing surveillance component compares internationally
  • influenza and influenza vacination
  • review findings and
  • seven recommendation for the vaccine safety monitoring system.

These files may not be suitable for users of assistive technology. Request an accessible format.